This lecture reviews pharmacologic use of medications commonly used in continence specialty practice. The focus includes pharmacologic management of overactive bladder, urogenital atrophy, and associated lower urinary tract symptoms. The lecture also covers pharmacotherapy in the management of urinary retention and stress urinary incontinence. We also discuss side effects of common drugs on lower urinary tract function and evolving evidence concerning the effects of the combination dietary ingredient/over-the-counter medication caffeine.
Contact hours available until 2/28/17.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: Christine Bradway, PhD, RN, CRNP: Consultant/Presenter Bureau: Direct Supply Inc. and Advisory Board: Astelles
Cheryl A. LeCroy, MSN, RN: Consultant: Allergan
Speaker Disclosures: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Identify pharmacologic options for managing lower urinary tract symptoms.
List newer pharmacotherapeutic options.
Describe emerging pharmacologic targets.
PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN,
Professor and Nurse Practitioner,
University of Virginia, Department of Urology
You must be logged in and own this session in order to